UPDATE ON CLINICAL TRIALS IN OI
OIFE supports and encourages the advancement into research to find new treatments, improve diagnosis and aid a better understanding of OI. We strive to keep the OI community informed of what clinical trials are ongoing. As part of this we are hosting our 2nd clinical trial update webinar on October the 22nd, 2024.
The goal of the webinar is to update the OI-community about ongoing clinical trials – both those who are recruiting and others.
The target group is anyone interested in OI-related research – both OI professionals, industry and people with OI and their families can attend.
The event is free and you can register through this link: https://tinyurl.com/OIFEclinicaltrial
The webinar will include a short update from the following trials:
- The Cosmic and the Orbit trials (setrusumab)
- EVENITY Ph3 study (romosozumab in children with OI)
- The BoostB4 trial (stem cells)
- The Topaz trial (teriparatide and zolendronate)
- The MOI-A trial (Losartan)
- Osteoanabolic treatment in OI caused by WNT mutations (Germany)
- Project on Paediatric Cross-Border Clinical Trials
More information can be found on this page.
